2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).

Lyon, Alexander R; López-Fernández, Teresa; Couch, Liam S; Asteggiano, Riccardo; Aznar, Marianne C; Bergler-Klein, Jutta; Boriani, Giuseppe; Cardinale, Daniela; Cordoba, Raul; Cosyns, Bernard; Cutter, David J; de Azambuja, Evandro; de Boer, Rudolf A; Dent, Susan F; Farmakis, Dimitrios; Gevaert, Sofie A; Gorog, Diana A; Herrmann, Joerg; Lenihan, Daniel; Moslehi, Javid; Moura, Brenda; Salinger, Sonja S; Stephens, Richard; Suter, Thomas M; Szmit, Sebastian; Tamargo, Juan; Thavendiranathan, Paaladinesh; Tocchetti, Carlo G; van der Meer, Peter; van der Pal, Helena J H

Lyon, Alexander R; López-Fernández, Teresa; Couch, Liam S; Asteggiano, Riccardo; Aznar, Marianne C; Bergler-Klein, Jutta; Boriani, Giuseppe; Cardinale, Daniela; Cordoba, Raul; Cosyns, Bernard; Cutter, David J; de Azambuja, Evandro; de Boer, Rudolf A; Dent, Susan F; Farmakis, Dimitrios; Gevaert, Sofie A; Gorog, Diana A; Herrmann, Joerg; Lenihan, Daniel; Moslehi, Javid; Moura, Brenda; Salinger, Sonja S; Stephens, Richard; Suter, Thomas M; Szmit, Sebastian; Tamargo, Juan; Thavendiranathan, Paaladinesh; Tocchetti, Carlo G; van der Meer, Peter; van der Pal, Helena J H.

Afiliação

Lyon AR; (United Kingdom).
López-Fernández T; (Spain).
Couch LS; (United Kingdom).
Asteggiano R; (Italy).
Aznar MC; (United Kingdom).
Bergler-Klein J; (Austria).
Boriani G; (Italy).
Cardinale D; (Italy).
Cordoba R; (Spain).
Cosyns B; (Belgium).
Cutter DJ; (United Kingdom).
de Azambuja E; (Belgium).
de Boer RA; (Netherlands).
Dent SF; (United States of America).
Farmakis D; (Cyprus).
Gevaert SA; (Belgium).
Gorog DA; (United Kingdom).
Herrmann J; (United States of America).
Lenihan D; (United States of America).
Moslehi J; (United States of America).
Moura B; (Portugal).
Salinger SS; (Serbia).
Stephens R; (United Kingdom).
Suter TM; (Switzerland).
Szmit S; (Poland).
Tamargo J; (Spain).
Thavendiranathan P; (Canada).
Tocchetti CG; (Italy).
van der Meer P; (Netherlands).
van der Pal HJH; (Netherlands).

Eur Heart J ; 43(41): 4229-4361, 2022 11 01.

Article em En | MEDLINE | ID: mdl-36017568

Assuntos

Antineoplásicos; Hematologia; Neoplasias; Radioterapia (Especialidade); Humanos; Oncologia; Neoplasias/tratamento farmacológico; Coração; Antineoplásicos/uso terapêutico

Palavras-chave

Amyloid light-chain cardiac amyloidosis; Androgen deprivation therapy; Anthracycline; Arrhythmias; Atrial fibrillation; Biomarkers; Cancer; Cancer survivors; Carcinoid syndrome; Cardiac magnetic resonance; Cardiac tumour; Cardio-oncology; Cardiotoxicity; Chemotherapy; Coronary artery disease; Echocardiography; Fluoropyrimidine; Guidelines; Haematopoietic stem cell transplantation; Heart failure; Hormone therapy; Hypertension; Immunotherapy; Ischaemic heart disease; Myocarditis; Pericardial disease; Proteasome inhibitors; Pulmonary hypertension; QTc prolongation; Radiotherapy; Risk stratification; Strain; Thrombosis; Trastuzumab; Valvular heart disease; Vascular endothelial growth factor inhibitors (VEGFi); Venous thromboembolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia (Especialidade) / Hematologia / Neoplasias / Antineoplásicos Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur Heart J Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google